TrialThe Lancet. Respiratory medicine2021

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.

Robert S Wallis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.